Facebook
Twitter
LinkedIn
Forward
Hormone Therapy for Gender Affirmation
Activity description
These materials are only intended for those that attended the live activity held March 21, 2024.
This activity was designed to equip health care professionals with the knowledge and skills necessary to provide compassionate, informed and comprehensive care to transgender and gender-diverse individuals seeking hormone therapy for gender affirmation. Current options for feminizing, anti-androgen and masculinizing hormones will be reviewed, including associated risks and monitoring guidelines. Participants will learn how to create an inclusive health care environment that incorporates a multidisciplinary approach to gender-affirming care and best practices in the management and support of patients undergoing gender transition, with an emphasis on a patient-centered approach, informed consent and the adaptation of care plans to meet the evolving needs and goals of patients.
Provided by
This activity is jointly provided by Optum Health Education and Optum Corporate Strategy.
Commercial support
There was no commercial support received for this activity.
Required hardware/software
Please ensure you are using the web-browser Chrome and disable any pop-up blocking software. Click here for information on how to enable pop-ups.
Target Audience
This activity is designed to meet the educational needs of nurses, nurse practitioners, PAs and physicians who have an interest in obtaining the knowledge and skills necessary to provide compassionate, informed and comprehensive care to transgender and gender-diverse individuals seeking hormone therapy for gender affirmation
Learning Objectives
At the end of this educational activity, participants should be able to:
- Discuss the critical roles of checking personal biases and utilizing a multidisciplinary approach to provide non-judgmental and patient-centered care for transgender and gender-diverse individuals seeking gender affirming care.
- Identify the current options for feminizing hormones, anti-androgens and masculinizing hormones, including their administration methods, dosages and approaches to monitoring and explain how to adjust treatments based on patient responses and goals.
- Describe the importance of a patient-centered approach that builds rapport and trust and clarifies the unique goals and needs of individuals regarding gender affirmation and transition.
- Recognize how to conduct focused histories and exams that are trauma-informed and identify risk factors and how to present appropriate treatment plan options that include informed consent.
Presenter
Juan Carlos Venis, MD, MPH, FAAFP
Assistant Professor of Clinical Family Medicine
Indiana University School of Medicine
Medical Director of Primary Care
Damien Center
Board Member
Damien Cares
Activity planner
Elizabeth Albert, MD
Clinical Activity Manager
Optum Health Education
Disclosures of relevant financial relationships
In accordance with the Accreditation Council for Continuing Medical Education's (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, Optum Health Education (OHE) requires all those in control of educational content to disclose their financial relationships with ineligible companies within the prior 24 months. Ineligible companies are defined by the ACCME as companies whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients. Individuals must disclose all financial relationships, regardless of the amount, with ineligible companies and regardless of their view of the relevance of the relationship to the education. OHE ensures that the content is independent of commercial bias.
The activity faculty or planners have no financial relationships to disclose.
Accreditation statement
In support of improving patient care, this activity has been planned and implemented by Optum Health Education and Optum Corporate Strategy. Optum Health Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit designation statements
Physicians
Optum Health Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
PAs
The American Academy of Physician Assistants (AAPA) accepts credit from organizations accredited by the ACCME.
Medical assistants
The American Association of Medical Assistants allows up to 30 non-AAMA recertification points for CMAs (AAMA) who are recertifying by continuing education. Please see the following link for more information: http://www.aama-ntl.org/continuing-education/ceus#nonaamaceus
Nurses
The participant will be awarded up to 1.0 contact hour(s) of credit for attendance and completion of supplemental materials.
Nurse practitioners
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts credit from organizations accredited by the ACCME and ANCC.
Attendance
A certificate of attendance will be provided to learners upon completion of activity requirements, enabling participants to register with licensing boards or associations that have not been pre-approved for credits. To apply for credit types not listed above, participants should use the procedure established by the specific organization with which they wish to obtain credit.
Available Credit
- 1.00 AMA - Physicians
- 1.00 ANCC - Nurses
- 1.00 Attendance - General Attendance
You must be logged into your account to participate in this activity. Get started by completing the “Evaluation”; then follow the prompts at the bottom of the screen. At the end of the activity, you will be able to view, save or print your certificate of participation. A complete listing of all of your activities can be found under “My Account,” “My Activities.”